RE: Bravo Vlad27 Nov 2025 07:36
@ GHD
Thanks for posting this yesterday below ref Vlad's LinkedIn post
Tatiana Schlossbergβs recent AML announcement has moved so many of us. Her honesty and courage in the face of such a devastating diagnosis shine a light on a painful reality, but also on a powerful truth: progress in AML treatment is accelerating faster than ever before.
Reading her story, I felt both heartbreak and a deep sense of resolve. Because today, unlike even a decade ago, we are finally standing at the beginning of a new chapter in AML therapy. A moment when advanced biologics, engineered immune cells, and next-generation CAR-T technologies are offering hope where previously there was so little.
At Hemogenyx Pharmaceuticals, this mission is personal. It fuels our work every single day. Behind every experiment, every breakthrough, every setback overcome there is the image of someone like Tatiana, and the belief that future patients deserve more options and more time.
AML is one of the toughest battles anyone can face. But science is rising to meet it. And the speed of innovation gives us real, tangible reasons to believe that tomorrowβs treatments will not look like yesterdayβs.
π Hope isnβt abstract. Itβs being built, cell by cell, discovery by discovery, for the people who need it most.
hashtag#AML hashtag#CancerResearch hashtag#CellTherapy hashtag#BiotechInnovation hashtag#HemogenyxPharmaceuticals hashtag#HopeThroughScience